Navigation Links
Thermo Fisher Scientific Explores Anti-cancer Therapeutic for Gene Therapy
Date:8/24/2017

The use of gene therapy is well studied due to its potential to treat cancer, the second leading cause of death worldwide. The goal of gene therapy is to introduce functional genetic material into human cells to be transcribed and translated in order to regulate, repair or suppress a molecular mechanism that contributes to a disease state.

Compared to traditional cancer therapies such as surgery, chemotherapy or radiation therapy, gene therapy is a more personalized and targeted approach because it is based on understanding the genetic profile of a patient’s tumor. The cytokine Interleukin-24 (IL-24), is of special interest for gene therapy because of its selective killing effect on numerous cancer cell types while having no effect on corresponding normal cells.

In this webinar, participants will learn how IL-24 treatment kills cancer cells and ultimately better understand how cell lines are used to decipher molecular signaling pathways for the development of anti-cancer therapeutics.

For this event, Thermo Fisher Scientific has arranged for Leah Persaud, a doctoral candidate at the Lehman College, City University of New York, to be the speaker.

Persaud completed her undergraduate degrees in biology and forensic science from the University of New Haven in Connecticut. As an undergraduate, she performed research on highly specific DNA nucleases for gene therapy at Justus Liebig University in Giessen, Germany. Currently, she is a doctoral candidate at the City University of New York Graduate Center, working in Dr. Moira Sauane's cancer research lab at Lehman College.

LabRoots will host the event September 28, 2017, beginning at 10:00 a.m. PDT. To read more about this event, discover what continuing education credits will be offered, or to register for free, click here.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $18 billion and more than 55,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit http://www.thermofisher.com.

About LabRoots
LabRoots is the leading scientific social networking website, which provides daily scientific trending news, as well as produces educational virtual events and webinars, on the latest discoveries and advancements in science. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Read the full story at http://www.prweb.com/releases/2017/08/prweb14630224.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Thermo Fisher Scientific Showcases Cell Reprogramming in Treatment-Resistant Prostate Cancer
2. Thermo Fisher Scientific Addresses the Antibody Reproducibility Crisis with Panel Discussion
3. Thermo Fisher Scientific Shares Applications of Targeted Next-generation Sequencing Panels in Neurodevelopmental Disorder Research
4. Thermo Fisher Scientific Webinar to Introduce High Content Imaging and Analysis for Drug Discovery
5. Thermo Fisher Scientific Demonstrates Improved differentiation of Stem Cell-derived Neurons and Downstream Applications
6. Thermo Fisher Scientific to Showcase Advances in Flow Cytometry in New Webinar
7. Save with H-B Verification Thermometers Calibrated for Specific Applications
8. American Academy of Thermology’s Annual Meeting & Scientific Session Receives ACCME Accreditation, Adds New Speakers & Workshop
9. CosmosID Launches Metagenomic and Antibiotic Resistance Application in Thermo Fisher Cloud
10. USPTO issues patent for "Preservation by Vaporization" technology, allowing manufacture of thermostable vaccines and other fragile biopharmaceuticals
11. PositiveID Corporations Thermomedics Subsidiary Signs Deals with Five New Healthcare Products Distributors in January
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... N.C. (PRWEB) , ... October 11, 2017 , ... ... ARCS® Foundation President Andi Purple announced Dr. Suneel I. Sheikh, the co-founder, ... ( ASTER Labs ), Inc. has been selected for membership in ARCS ...
(Date:10/11/2017)... BioMarketing, a leading provider of patient support solutions, has announced ... network, which will launch this week. The VMS CNEs will ... to enhance the patient care experience by delivering peer-to-peer education ... professionals to help women who have been diagnosed and are ... ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... San Diego-based ... of its corporate rebranding initiative announced today. The bold new look is part ... as the company moves into a significant growth period. , It will also expand ...
(Date:10/10/2017)... SomaGenics announced the receipt of a Phase ... (Single Cell), expected to be the first commercially available ... from single cells using NGS methods. The NIH,s recent ... development of approaches to analyze the heterogeneity of cell ... for measuring levels of mRNAs in individual cells have ...
Breaking Biology Technology:
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/29/2017)... CHICAGO , March 29, 2017  higi, the ... ecosystem in North America , today ... Partners and the acquisition of EveryMove. The new investment ... extensive set of tools to transform population health activities ... and lifestyle data. higi collects and secures ...
(Date:3/24/2017)... -- Research and Markets has announced the addition of ... - Industry Forecast to 2025" report to their offering. ... The Global Biometric Vehicle ... around 15.1% over the next decade to reach approximately $1,580 million ... estimates and forecasts for all the given segments on global as ...
Breaking Biology News(10 mins):